Inmolecule Nanotech (XPAR:MLINA) Other Current Receivables: €1.12 Mil (As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Other Current Receivables?

Inmolecule Nanotech XPAR:MLINA 6 Other Current Receivables is €1.12 Mil as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Inmolecule Nanotech's Other Current Receivables for the quarter that ended in Dec. 2024 was €1.12 Mil.

Inmolecule Nanotech's quarterly Other Current Receivables increased from . 20 (€0.00 Mil) to Dec. 2023 (€0.10 Mil) and increased from Dec. 2023 (€0.10 Mil) to Dec. 2024 (€1.12 Mil).

Inmolecule Nanotech's annual Other Current Receivables increased from . 20 (€0.00 Mil) to Dec. 2023 (€0.10 Mil) and increased from Dec. 2023 (€0.10 Mil) to Dec. 2024 (€1.12 Mil).

Inmolecule Nanotech Other Current Receivables Related Terms

Inmolecule Nanotech Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Other Current Receivables Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Other Current Receivables
0.10 1.12

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Other Current Receivables 0.10 1.12
XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €1.12 Mil mean?
Inmolecule Nanotech (XPAR:MLINA) has a Other Current Receivables of €1.12 Mil as of Dec. 2024. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Other Current Receivables too high?
Inmolecule Nanotech's current Other Current Receivables is €1.12 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Other Current Receivables compare to VRTX and REGN?
Inmolecule Nanotech's Other Current Receivables of €1.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Other Current Receivables is €1.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Other Current Receivables of €1.12 Mil. The current Other Current Receivables is €1.12 Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Other Current Receivables is €1.12 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price